Previous close | 2.9800 |
Open | N/A |
Bid | 2.4500 |
Ask | 3.8000 |
Strike | 2.50 |
Expiry date | 2024-07-19 |
Day's range | 2.9800 - 2.9800 |
Contract range | N/A |
Volume | |
Open interest | 1 |
There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although...
CollPlant Biotechnologies (Nasdaq: CLGN), a regenerative and aesthetics medicine company developing innovative technologies and products based on its non-animal-derived recombinant human collagen (rhCollagen) for tissue regeneration and organ manufacturing, today announced financial results for the full year ended December 31, 2023 and provided a corporate update.
CollPlant Biotechnologies (Nasdaq: CLGN), a regenerative and aesthetics medicine company developing innovative technologies and products based on its non-animal-derived collagen, today announced that it will report financial results for the full year of 2023 on Thursday, April 4, 2024, before the market open. The Company will then host a conference call and webcast to discuss its financial results and corporate updates on April 4th at 10:00 am Eastern Daylight Time.